UnitedHealth Group (NYSE: UNH) reported earnings on July 19. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), UnitedHealth Group met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share improved.

Gross margins expanded, operating margins dropped, net margins dropped.

Revenue details
UnitedHealth Group recorded revenue of $27.27 billion. The 17 analysts polled by S&P Capital IQ expected net sales of $27.33 billion on the same basis. GAAP reported sales were 8.0% higher than the prior-year quarter's $25.23 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.27. The 22 earnings estimates compiled by S&P Capital IQ anticipated $1.19 per share. GAAP EPS of $1.27 for Q2 were 9.5% higher than the prior-year quarter's $1.16 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 26.6%, 20 basis points better than the prior-year quarter. Operating margin was 8.2%, 10 basis points worse than the prior-year quarter. Net margin was 4.9%, 10 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $27.49 billion. On the bottom line, the average EPS estimate is $1.27.

Next year's average estimate for revenue is $109.95 billion. The average EPS estimate is $5.01.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 3,295 members out of 3,447 rating the stock outperform, and 153 members rating it underperform. Among 975 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 956 give Unitedhealth Group a green thumbs-up, and 19 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on UnitedHealth Group is outperform, with an average price target of $68.38.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Motley Fool newsletter services have recommended buying shares of UnitedHealth Group. Motley Fool newsletter services have recommended creating a diagonal call position in UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.